Conantokins inhibit NMDAR-dependent calcium influx in developing rat hippocampal neurons in primary culture with resulting effects on CREB phosphorylation

Molecular and Cellular Neuroscience

Volumn 45, Issue 2, 2010, Pages 163-172

  Huang, Luoxiu ^a   Balsara, Rashna D ^a   Sheng, Zhenyu ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Calcium imaging; Conantokins; Electrophysiology; Ion channels; Neuron development; Neuron signaling; NMDA receptor

Indexed keywords

CALCINEURIN; CALCIUM ION; CONANTOKIN G; CONANTOKIN R[1-17]; CONANTOKIN T; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MARINE TOXIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM TRANSPORT; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL CULTURE TECHNIQUES; CONOTOXINS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MOLLUSK VENOMS; NEURONS; PEPTIDES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

RATTUS;

EID: 77955769070     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.06.007     Document Type: Article

References (59)

1. Alex A.B., Baucum A.J., Wilcox K.S. Effect of conantokin G on NMDA receptor-mediated spontaneous EPSCs in cultured cortical neurons. J. Neurophysiol. 2006, 96:1084-1092.
2. Auberson Y.P., Allgeier H., Bischoff S., Lingenhoehl K., Moretti R., Schmutz M. 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg. Med. Chem. Lett. 2002, 12:1099-1102.
3. Barria A., Malinow R. NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 2005, 48:289-301.
4. Barton M.E., White H.S., Wilcox K.S. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs. Epilepsy Res. 2004, 59:13-24.
5. Bialojan C., Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 1988, 256:283-290.
6. Bito H., Deisseroth K., Tsien R.W. CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996, 27:1203-1214.
7. Bito H., Takemoto-Kimura S. Ca(2+)/CREB/CBP-dependent gene regulation: a shared mechanism critical in long-term synaptic plasticity and neuronal survival. Cell Calcium 2003, 34:425-430.
8. Blandl T., Zajicek J., Prorok M., Castellino F.J. Sequence requirements for the N-methyl-d-aspartate receptor antagonist activity of conantokin-R. J. Biol. Chem. 2001, 276:7391-7396.
9. Borza I., Domány G. NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore. Curr. Top. Med. Chem. 2006, 6:687-695.
10. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Cui J.K., Tu S.C., Kevin A.S.K., Nakanishi N., Tong G., Lipton S.A., Zhang D.X. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2002, 415:793-798.
11. Chazot P.L. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr. Med. Chem. 2004, 11:389-396.
12. Cho K.O., Hunt C.A., Kennedy M.B. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 1992, 9:929-942.
13. Deisseroth K., Bito H., Tsien R.W. Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 1996, 16:89-101.
14. Donevan S.D., McCabe R.T. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-d-aspartate receptors. Mol. Pharmacol. 2000, 58:614-623.
15. Furukawa H., Singh S.K., Mancusso R., Gouaux E. Subunit arrangement and function in NMDA receptors. Nature 2005, 438:185-192.
16. Gardoni F., Caputi A., Cimino M., Pastorino L., Cattabeni F., Di Luca M. Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities. J. Neurochem. 1998, 71:1733-1741.
17. Gardoni F., Mauceri D., Malinverno M., Polli F., Costa C., Tozzi A., Siliquini S., Picconi B., Cattabeni F., Calabresi P., Di Luca M. Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J. Neurosci. 2009, 29:669-677.
18. Gowd K.H., Twede V., Watkins M., Krishnan K.S., Teichert R.W., Bulaj G., Olivera B.M. Conantokin-P, an unusual conantokin with a long disulfide loop. Toxicon 2008, 52:203-213.
19. Groth R.D., Dunbar R.L., Mermelstein P.G. Calcineurin regulation of neuronal plasticity. Biochem. Biophys. Res. Commun. 2003, 311:1159-1171.
20. Haack J.A., Rivier J., Parks T.N., Mena E.E., Cruz L.J., Olivera B.M. Conantokin-T A γ-carboxyglutamate-containing peptide with N-methyl-d-aspartate antagonist activity. J. Biol. Chem. 1990, 265:6025-6029.
21. Hagiwara M., Alberts A., Brindle P., Meinkoth J., Feramisco J., Deng T., Karin M., Shenolikar S., Montminy M. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 1992, 70:105-113.
22. Hardingham G.E., Bading H. Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim. Biophys. Acta 2002, 1600:148-153.
23. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 2002, 5:405-414.
24. Hovinga C.A. Novel anticonvulsant medications in development. Expert Opin. Investig. Drugs 2002, 11:1387-1406.
25. Jimenez E.C., Donevan S., Walker C., Zhou L.M., Nielsen J., Cruz L.J., Armstrong H., White H.S., Olivera B.M. Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Res. 2002, 51:73-80.
26. Klein R.C., Galdzicki Z., Castellino F.J. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons. Neuropharmacology 1999, 38:1819-1829.
27. Klein R.C., Prorok M., Galdzicki Z., Castellino F.J. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-d-aspartate receptors. J. Biol. Chem. 2001, 276:26860-26867.
28. Kopnisky K.L., Chalecka-Franaszek E., Gonzalez-Zulueta M., Chuang D.M. Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities. Neuroscience 2003, 116:425-435.
29. Laube B., Hirai H., Sturgess M., Betz H., Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 1997, 18:493-503.
30. Malenka R.C., Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 1993, 16:521-527.
31. Malmberg A.B., Gilbert H., McCabe R.T., Basbaum A.I. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 2003, 101:109-116.
32. Mayer M.L., Westbrook G.L., Guthrie P.B. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984, 309:261-263.
33. McBain C.J., Mayer M.L. N-methyl-d-aspartic acid receptor structure and function. Physiol. Rev. 1994, 74:723-760.
34. McIntosh J., Olivera B.M., Cruz L., Gray W. γ-Carboxyglutamate in a neuroactive toxin. J. Biol. Chem. 1984, 259:14343-14346.
35. Muramatsu M., Lapiz M.D., Tanaka E., Grenhoff J. Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors. Eur. J. Neurosci. 1998, 10:2371-2379.
36. Nikam S.S., Meltzer L.T. NR2B selective NMDA receptor antagonists. Curr. Pharm. Des. 2002, 8:845-855.
37. Parsons J.N., Wiederrecht G.J., Salowe S., Burbaum J.J., Rokosz L.L., Kincaid R.L., O'Keefe S.J. Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex. J. Biol. Chem. 1994, 269:19610-19616.
38. Prorok M., Geng J.P., Warder S.E., Castellino F.J. The entire gamma-carboxyglutamic acid- and helical stack-domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor. Int. J. Pept. Protein Res. 1996, 48:281-285.
39. Rosenmund C., Feltz A., Westbrook G.L. Synaptic NMDA receptor channels have a low open probability. J. Neurosci. 1995, 15:2788-2795.
40. Sala C., Rudolph-Correia S., Sheng M. Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. J. Neurosci. 2000, 20:3529-3536.
41. Sassone-Corsi P., Visvader J., Ferland L., Mellon P.L., Verma I.M. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 1988, 12:1529-1538.
42. Sauerwald A., Hoesche C., Oschwald R., Kilimann M.W. The 5'-flanking region of the synapsin I gene. A G+C-rich, TATA- and CAAT-less, phylogenetically conserved sequence with cell type-specific promoter function. J. Biol. Chem. 1990, 265:14932-14937.
43. Schneggenburger R., López-Barneo J., Konnerth A. Excitatory and inhibitory synaptic currents and receptors in rat medial septal neurones. J. Physiol. 1992, 445:261-276.
44. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 1994, 368:144-147.
45. Sheng Z., Dai Q., Prorok M., Castellino F.J. Subtype-selective antagonism of N-methyl-d-aspartate receptor ion channels by synthetic conantokin peptides. Neuropharmacology 2007, 53:145-156.
46. Smith A.J., Owens S., Forsythe I.D. Characterisation of inhibitory and excitatory postsynaptic currents of the rat medial superior olive. J. Physiol. 2000, 529:681-698.
47. Strack S., Colbran R.J. Autophosphorylation-dependent targeting of calcium/calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl-d-aspartate receptor. J. Biol. Chem. 1998, 273:20689-20692.
48. Teichert R.W., Jimenez E.C., Twede V., Watkins M., Hollmann M., Bulaj G., Olivera B.M. Novel conantokins from conus parius venom are specific antagonists of NMDA receptors. J. Biol. Chem. 2007, 282:36905-36913.
49. Tovar K.R., Westbrook G.L. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 1999, 19:4180-4188.
50. Tovar K.R., Westbrook G.L. Mobile NMDA receptors at hippocampal synapses. Neuron 2002, 34:253-264.
51. Waxman E.A., Lynch D.R. N-methyl-d-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J. Biol. Chem. 2005, 280:29322-29333.
52. Wei F., Wang G.D., Kerchner G.A., Kim S.J., Xu H.M., Chen Z.F., Zhuo M. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat. Neurosci. 2001, 4:164-169.
53. Wei J., Dong M., Xiao C., Jiang F., Castellino F.J., Prorok M., Dai Q. Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice. Neurosci. Lett. 2006, 405:137-141.
54. White H.S., McCabe R.Y., Armstrong H., Donevan S.D., Cruz L.J., Abogadie F.C., Torres J., Rivier J.E., Paarmann I., Hollmann M., Olivera B.M. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J. Pharmacol. Exp. Ther. 2000, 292:425-432.
55. Williams A.J., Dave J.R., Lu X.M., Ling G., Tortella F.C. Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis. Eur. J. Pharmacol. 2002, 452:135-136.
56. Williams A.J., Ling G., McCabe R.T., Tortella F.C. Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia. NeuroReport 2002, 1e3:821-824.
57. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 1993, 44:851-859.
58. Wu L.J., Xu H., Ren M., Cao X., Zhuo M. Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex. Mol. Pain 2007, 3:11.
59. Xiao C., Huang Y., Dong M., Hu J., Hou S., Castellino F.J., Prorok M., Dai Q. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins. Neuropeptides 2008, 42:601-609.